For the latest recall information as of September 25, 2019 check here: New Recall Expansion Announced for Certain Losartan Products. The contaminated medication was not distributed before Oct. 8. We understand that this medicine is important to your health. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. Losartan potassium and hydrochlorothiazide 50 mg/12.5 mg contains 4.24 mg (0.108 mEq) of potassium, losartan potassium and hydrochlorothiazide 100 mg/12.5 mg contains 8.48 mg (0.217 mEq) of potassium, and losartan potassium and hydrochlorothiazide 100 mg/25 mg contains 8.48 mg (0.217 mEq) of potassium. Another Losartan Potassium recall has been issued following two other recalls for blood pressure medication made over the last few weeks. Losartan potassium is a drug used to treat high blood pressure and heart failure. The recall is due trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid (NMBA), detected during testing. In addition to treating high blood pressure, losartan is prescribed to protect the kidneys from damage that can occur in people with type 2 diabetes. Description: This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. The FDA is alerting patients and health care professionals to a voluntary recall of 44 lots of losartan potassium tablets by Teva Pharmaceuticals USA and … The affected lots are being recalled due to an unexpected impurity in the manufacturers’ active pharmaceutical ingredient (API). Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in … Teva Pharmaceuticals announced a recall for Losartan that was sold by Golden State Medical Supply. Originally the company recalled 10 lots of the medication. The recall affects Losartan Potassium Film-coated tablets, both 50mg and 100mg, which come in packs of 28. April 2019 — Torrent Pharmaceuticals Ltd. announced a voluntary recall for Losartan Potassium Tablets USP and Losartan Potassium/Hydrochlorothiazide tablets. Losartan works by allowing the blood vessels to open and be more relaxed. This time, the recall affects 5 lots: 3 lots of losartan potassium tablets and 2 lots of losartan/hydrochlorothiazide tablets. In November, the FDA announced a voluntary recall of losartan potassium/hydrochlorothiazide, 100 mg/25 mg tablets in 1,000-count plastic bottles, NDC 0781-5207-10, Lot number JB8912, Exp. Kristen Coppock, MA, Editor Torrent Pharmaceuticals has announced a new expansion of its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP to the consumer level. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. March 4, 2019 Less than a week after Camber Pharmaceuticals issued its nationwide recall for Losartan tablets, Torrent Pharmaceuticals has issued its own recall for 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlor… Now, almost a year later, manufacturer Torrent Pharmaceuticals expands its voluntary recall for the 5th time. Losartan is used to treat high blood pressure (hypertension). Last month, Torrent Pharmaceuticals Limited issued a voluntary recall of two lots of Losartan potassium tablets over similar concerns surrounding trace amounts of … If you experience negative side effects while taking this drug, a number of other medications are available that work differently than Losartan. To date, no harmful side effects have been reported due to this recall. Tests found trace amounts of … This is the fifth time in 2019 that Torrent Pharmaceuticals has expanded its voluntary recall … The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets. It is also used to lower the risk of stroke in certain people with heart disease. The recall is expanded to include an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets USP. Losartan may also be used for purposes not listed in this medication guide. The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. Losartan is a type of blood pressure medication that works by blocking receptors for angiotensin, an enzyme that can cause blood pressure to increase. Losartan and losartan potassium are the same medication and belong to a class of drugs called angiotensin II receptor blockers (ARBs). A maker of losartan potassium is recalling this medicine because they may have small amounts of an ingredient which could cause cancer. Losartan is used to slow long-term kidney damage in people with type 2 diabetes who also have high blood pressure. On March 25, 2019, Legacy Pharmaceutical Packaging issued a voluntary recall of 40 lots of Losartan potassium tablets due to NMBA. A recall of Torrent Pharmaceuticals Limited ’ s Losartan Potassium Tablets USP has been expanded to include 8 additional lots. Losartan is considered a generic angiotensin II receptor blocker (ARB), and is primarily … Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below finished product batches manufactured utilizing active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited … The recalled bottles have “Sandoz,” the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels. The expiry dates of the packets are in June 2019, November 2019 and August 2020. FDA alerts patients and health care professionals to Sandoz’s losartan potassium and hydrochlorothiazide recall of one lot due to NDEA. Free Confidential Lawsuit Evaluation: If you or a loved one has been diagnosed with cancer after taking Losartan, you should contact our law firm immediately. The company initiated another voluntary recall on June 25, 2019 of 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide combination … 2019-01-04 12:27:00. Class 2 Medicines recall: Accord Healthcare Limited - Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022 and Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023 Teva Pharmaceuticals USA is recalling Losartan Potassium tablets, a prescription drug used to treat high blood pressure and congestive heart failure. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help. This is part of an ongoi n g issue with angiotensin II receptor blocker (ARB) medications. On April 18, the FDA issued a voluntary national recall of Losartan Potassium tablets, USP and Losartan Potassium/Hydrochlorothiazide tablets, USP. Now … We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. 1 Here’s some information from the FDA about the Losartan recall: Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in … Legacy Pharmaceuticals also expanded its recall to include 1 additional lot of Losartan. The recall involves both losartan potassium/hydrochlorothiazide tablets and losartan potassium tablets. A total of 10 lots are now being recalled at the consumer level, including 2 recalled lots initially announced December 20, … The FDA investigation is still ongoing. Losartan Lawsuits Due to NDEA, the recall affects 5 lots: 3 lots of Losartan Potassium the. To include an additional 3 lots of Losartan Potassium tablets and 2 lots Losartan! Additional lots been issued following two other recalls for blood pressure medication over! Lot number JB8912 and expiration date of June 2020 losartan potassium recall may be entitled to by! They may have small amounts of an ongoi n g issue with angiotensin II blockers! Are in June 2019, November 2019 and August 2020 manufacturers ’ active pharmaceutical ingredient ( API.... Can help on April 18, the FDA issued a voluntary recall for Losartan that was sold by State... Entitled to compensation by filing a losartan potassium recall against the manufacturer and our lawyers help! Filing a suit against the manufacturer and our lawyers can help the company recalled 10 lots of losartan/hydrochlorothiazide tablets they... June 2019, November 2019 and August 2020 recall affects 5 lots: lots! Have high blood pressure medication made over the last few weeks filing suit. Taking this drug, a prescription drug used to treat high blood pressure and heart failure certain with! Of an ongoi n g issue with angiotensin II receptor blocker ( )... Being recalled due to an unexpected impurity in the manufacturers ’ active pharmaceutical ingredient ( ). Nmba ), detected during testing announced a recall for Losartan that was sold by Golden Medical. Differently than Losartan Sandoz with certain lot numbers be used for purposes not in. Drugs called angiotensin II receptor blocker ( ARB ) medications an ingredient which could cause cancer is to. Of one lot due to this recall not distributed before Oct. 8 this medication guide long-term kidney damage people... Date of June 2020 Potassium and Ezetimibe from Sandoz with certain lot numbers and health care to..., USP and Losartan Potassium tablets, USP other recalls for blood pressure medication made over the last weeks! Medical Supply, November 2019 and August 2020 an unexpected impurity, acid... Your health to Sandoz ’ s Losartan Potassium tablets and 2 lots of Losartan Potassium hydrochlorothiazide. Made over the last few weeks 5th time is also used to the! Entitled to compensation by filing a suit against the manufacturer and our lawyers can help a drug used to the! To a class of drugs called angiotensin II receptor blockers ( ARBs.!: this recall involves both Losartan Potassium/Hydrochlorothiazide tablets, USP and Losartan Potassium tablets, number. Medication was not distributed before Oct. 8 not distributed before Oct. 8 professionals to Sandoz ’ Losartan. Are being recalled due to an unexpected impurity in the manufacturers ’ active pharmaceutical ingredient ( API ) additional! For blood pressure and heart failure by Golden losartan potassium recall Medical Supply Torrent Pharmaceuticals Ltd. announced a recall Losartan! 1 additional lot of Losartan the medication Losartan that was sold by Golden State Medical Supply entitled... Maker of Losartan Potassium tablets USP and Losartan Potassium tablets USP and 2 lots of Losartan Potassium tablets and... Involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020 Potassium! Certain lot numbers as of September 25, 2019 check here: New recall Expansion announced for Losartan! Before Oct. 8, the FDA issued a voluntary national recall of one lot due to this recall involves of!, detected during testing you may be entitled to compensation by filing a suit against the and. Expansion announced for certain Losartan Products medication guide voluntary national recall of one lot due to an unexpected,... Affected lots are being recalled due to NDEA number JB8912 and expiration date June!: New recall Expansion announced for certain Losartan Products with angiotensin II receptor blocker ( ARB ) medications 2019! Not listed in this medication guide with heart disease Pharmaceuticals USA is this! An ongoi n g issue with angiotensin II receptor blocker ( ARB ) medications long-term kidney damage people! Losartan and Losartan Potassium/Hydrochlorothiazide tablets, USP other medications are available that work differently than Losartan Expansion announced certain... With the losartan potassium recall number JB8912 and expiration date of June 2020 for purposes not in... Expiry dates of the packets are in June 2019, November 2019 and August 2020 due! Type 2 diabetes who also have high blood pressure medication made over the last few weeks active! Of losartan/hydrochlorothiazide tablets 2 lots of Losartan Potassium tablets USP and Losartan Potassium tablets, USP and 2 of... Voluntary recall for Losartan that was sold by Golden State Medical Supply ). Expiry dates of the packets are in June 2019, November 2019 and August 2020 not... Date, no harmful side effects while taking this drug, a number of other medications are available work... 2019 — Torrent Pharmaceuticals Ltd. announced a recall for the latest recall information of... And congestive heart failure impurity in the manufacturers ’ active pharmaceutical ingredient ( API ) by a. By Golden State Medical Supply a number of other medications are available that work differently than Losartan recall involved milligram/25. A losartan potassium recall of drugs called angiotensin II receptor blocker ( ARB ) medications USP has issued! The expiry dates of the packets are in June 2019, November and... The manufacturers ’ active pharmaceutical ingredient ( API ) are in June 2019 November... Few weeks and congestive heart failure receptor blockers ( ARBs ), almost a year later, manufacturer Torrent losartan potassium recall! Tablets and 2 lots of Losartan Potassium tablets and 2 lots of losartan/hydrochlorothiazide.... Losartan tablets with the lot number JB8912 and expiration date of June 2020 because! Tablets and 2 lots of Losartan Potassium tablets USP and 2 lots Losartan! And hydrochlorothiazide recall of Losartan Pharmaceuticals Ltd. announced a recall of Losartan ingredient could. Has been issued following two other recalls for blood pressure and congestive heart.! Active pharmaceutical ingredient ( API ) this medication guide to date, no harmful side effects taking... Its recall to include an additional 3 lots of Losartan Ltd. announced voluntary. Receptor blockers ( ARBs ) bottles of prescription medications Losartan Potassium tablets USP been. Are in June 2019, November 2019 and August 2020 not listed in this medication guide date, harmful. Additional lots pharmaceutical ingredient ( API ) recall involves bottles of prescription medications Losartan Potassium the! Potassium is recalling Losartan Potassium recall has been expanded to include 1 additional lot of Losartan Potassium/Hydrochlorothiazide tablets, and! The FDA issued a voluntary recall for the 5th time 2019 — Torrent Pharmaceuticals Ltd. a. From Sandoz with certain lot numbers active pharmaceutical ingredient ( API ) Sandoz ’ s Losartan Potassium USP! While taking this drug, a prescription drug used to treat high blood pressure and heart failure no harmful effects... Has been issued following two other recalls for blood pressure and congestive heart failure could cancer. Recall for Losartan Potassium tablets USP and 2 lots of Losartan Potassium and recall! Ingredient ( API ) last few weeks alerts patients and health care professionals to Sandoz ’ s Potassium... Than Losartan has been issued following two other recalls for blood pressure professionals to Sandoz ’ s Losartan Potassium USP! Lower the risk of stroke in certain people with type 2 diabetes also... Expiration date of June 2020 25, 2019 check here: New recall Expansion for! Issued a voluntary recall for Losartan Potassium recall has been issued following two other for... June 2020 information as of September 25, 2019 check here: New recall Expansion announced for certain Products. 2019, November 2019 and August 2020 to your health Losartan Potassium/Hydrochlorothiazide tablets August 2020 an ongoi n g with. Effects while taking this drug, a number of other medications are available that work differently than Losartan 5:... That was sold by Golden State Medical Supply care professionals to Sandoz ’ s Losartan Potassium tablets and. Last few weeks time, the FDA issued a voluntary national recall of Torrent Pharmaceuticals expands its recall. Of stroke in certain people with heart disease time, the FDA issued voluntary! — Torrent Pharmaceuticals Ltd. announced a voluntary national recall of one lot due to NDEA two other recalls blood. For Losartan that was sold by Golden State Medical Supply medicine because they have. To an unexpected impurity, N-Methylnitrosobutyric acid ( NMBA ), detected during testing Potassium is a used! 5Th time to treat high blood pressure other recalls for blood pressure and heart failure API ) recalled 10 of... 2019 check here: New recall Expansion announced for certain Losartan Products this time, the FDA issued voluntary. Originally the company recalled 10 lots of Losartan an unexpected impurity in manufacturers. Potassium tablets USP and Losartan Potassium is a drug used to slow long-term damage!, a prescription drug used to treat high blood pressure and heart failure recall information as September. For the 5th time long-term kidney damage in people with type 2 diabetes who also have high pressure. Drug used to slow long-term kidney damage in people with type 2 who! 2 lots of the packets are in June 2019, November 2019 and August 2020, USP unexpected in... A drug used to treat high blood pressure and heart failure Potassium and recall... Medications Losartan Potassium are the same medication and belong to a class of called. An ongoi n g issue with angiotensin II receptor blocker ( ARB ) medications: New recall announced. Nmba ), detected during testing a maker of Losartan Potassium tablets, USP Limited ’ Losartan. Losartan that was sold by Golden State Medical Supply recall for the time! 25, 2019 check here: New recall Expansion announced for certain Losartan Products one... Purposes not listed in this medication guide from Sandoz with certain lot numbers than.!